Integra LifeSciences Holdings Corporation
IART · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,404 | -$484,073 | -$25,293 | $19,435 |
| Dep. & Amort. | $38,522 | $37,692 | $37,188 | $37,589 |
| Deferred Tax | -$8,653 | -$44,831 | -$1,832 | -$6,988 |
| Stock-Based Comp. | $5,580 | $5,295 | $1,870 | $7,152 |
| Change in WC | $24,298 | -$18,032 | -$24,654 | -$11,987 |
| Other Non-Cash | -$13,437 | $512,868 | $1,464 | $5,539 |
| Operating Cash Flow | $40,906 | $8,919 | -$11,257 | $50,740 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15,156 | -$20,146 | -$28,920 | -$29,600 |
| Net Acquisitions | $0 | $0 | $0 | $4,183 |
| Inv. Purchases | -$432 | -$1,502 | -$7,000 | -$4,129 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $35,250 |
| Other Inv. Act. | $0 | $0 | $0 | -$9,953 |
| Investing Cash Flow | -$15,588 | -$21,648 | -$35,920 | -$4,249 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$9,971 | -$6,842 | $39,156 | -$4,543 |
| Stock Issued | $0 | $0 | $957 | $0 |
| Stock Repurch. | $0 | -$221 | $0 | -$2,471 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$274 | -$14,076 | -$4,736 | -$136 |
| Financing Cash Flow | -$10,245 | -$21,139 | $35,377 | -$7,150 |
| Forex Effect | -$801 | $12,678 | $4,529 | -$8,123 |
| Net Chg. in Cash | $14,272 | -$21,190 | -$7,271 | $31,218 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $217,914 | $239,104 | $246,375 | $215,157 |
| End Cash | $232,186 | $217,914 | $239,104 | $246,375 |
| Free Cash Flow | $25,750 | -$11,227 | -$40,177 | $11,187 |